Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease
- PMID: 29118087
- PMCID: PMC5791072
- DOI: 10.1681/ASN.2017070819
Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease
Abstract
The association of overweight/obesity with disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD) remains untested. We hypothesized that overweight/obesity associates with faster progression in early-stage ADPKD. Overall, 441 nondiabetic participants with ADPKD and an eGFR>60 ml/min per 1.73 m2 who participated in the Halt Progression of Polycystic Kidney Disease Study A were categorized on the basis of body mass index (BMI; calculated using nonkidney and nonliver weight) as normal weight (18.5-24.9 kg/m2; reference; n=192), overweight (25.0-29.9 kg/m2; n=168), or obese (≥30 kg/m2; n=81). We evaluated the longitudinal (5-year) association of overweight/obesity with change in total kidney volume (TKV) by magnetic resonance imaging using linear regression and multinomial logistic regression models. Among participants, mean±SD age was 37±8 years, annual percent change in TKV was 7.4%±5.1%, and BMI was 26.3±4.9 kg/m2 The annual percent change in TKV increased with increasing BMI category (normal weight: 6.1%±4.7%, overweight: 7.9%±4.8%, obese: 9.4%±6.2%; P<0.001). In the fully adjusted model, higher BMI associated with greater annual percent change in TKV (β=0.79; 95% confidence interval [95% CI], 0.18 to 1.39, per 5-unit increase in BMI). Overweight and obesity associated with increased odds of annual percent change in TKV ≥7% compared with <5% (overweight: odds ratio, 2.02; 95% CI, 1.15 to 3.56; obese: odds ratio, 3.76; 95% CI, 1.81 to 7.80). Obesity also independently associated with greater eGFR decline (slope) versus normal weight (fully adjusted β =-0.08; 95% CI, -0.15 to -0.02). In conclusion, overweight and, particularly, obesity are strongly and independently associated with rate of progression in early-stage ADPKD.
Keywords: ADPKD; clinical epidemiology; obesity; renal function decline; total kidney volume.
Copyright © 2018 by the American Society of Nephrology.
Figures
References
-
- Somlo S, Chapman AB: Autosomal dominant polycystic kidney disease. In: Schrier’s Diseases of the Kidney, 9th Ed., edited by Coffman TM, Falk RJ, Molitoris BA, Neilson EG, Schrier RW, Philadelphia, Lippincott Williams & Wilkins, 2012, pp 519–563
-
- Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 369: 1287–1301, 2007 - PubMed
-
- Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr., Glockner JF, Wetzel LH, Brummer ME, O’Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort : Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 64: 1035–1045, 2003 - PubMed
-
- Schrier RW, McFann KK, Johnson AM: Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int 63: 678–685, 2003 - PubMed
-
- Helal I, McFann K, Reed B, Yan XD, Schrier RW: Changing referral characteristics of patients with autosomal dominant polycystic kidney disease. Am J Med 126: 832.e7–832.e11, 2013 - PubMed
Publication types
MeSH terms
Grants and funding
- U01 DK062401/DK/NIDDK NIH HHS/United States
- M01 RR000585/RR/NCRR NIH HHS/United States
- UL1 RR024989/RR/NCRR NIH HHS/United States
- P30 DK090728/DK/NIDDK NIH HHS/United States
- U01 DK062402/DK/NIDDK NIH HHS/United States
- UL1 RR025780/RR/NCRR NIH HHS/United States
- UL1 TR001064/TR/NCATS NIH HHS/United States
- UL1 RR025752/RR/NCRR NIH HHS/United States
- M01 RR000039/RR/NCRR NIH HHS/United States
- UL1 RR033179/RR/NCRR NIH HHS/United States
- P30 DK106912/DK/NIDDK NIH HHS/United States
- UL1 TR000001/TR/NCATS NIH HHS/United States
- K01 DK103678/DK/NIDDK NIH HHS/United States
- M01 RR001032/RR/NCRR NIH HHS/United States
- M01 RR000054/RR/NCRR NIH HHS/United States
- M01 RR023940/RR/NCRR NIH HHS/United States
- UL1 TR000135/TR/NCATS NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- U01 DK062408/DK/NIDDK NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- M01 RR000051/RR/NCRR NIH HHS/United States
- R01 DK044863/DK/NIDDK NIH HHS/United States
- UL1 TR001082/TR/NCATS NIH HHS/United States
- UL1 TR001102/TR/NCATS NIH HHS/United States
- U01 DK082230/DK/NIDDK NIH HHS/United States
- UL1 RR024150/RR/NCRR NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- UL1 RR025008/RR/NCRR NIH HHS/United States
- U01 DK062410/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous